digital twins

R&D

How innovative trial approaches are advancing rare disease r...

Innovative trial designs that harness data augmentation, RWD, and the power of AI are enabling a new era of rare disease research.

R&D

pharmaphorum podcast Episode 202, Piet van der Graaf, Certara

On digital twins in rare disease research, with Piet van der...

Piet van der Graaf, Senior VP at Certara discusses the potential of digital twins in rare diseases research.

R&D

The impact of generative AI on protein design for drug disco...

Artificial Intelligence (AI) is at the heart of the latest global transformation, not least within the biopharmaceutical industry.

Digital

Digital twins and virtual trials: A new era in rare disease ...

Integrating digital twins and virtual trials with AI in clinical research will usher in a new era of drug development for rare diseases.

Digital

Simulated clinical trial populations and AI scalability

AI might still be in the modish buzzword stage, but discussions exploring the potential for its scaling within life sciences are critical.

News

Lab space in CRUK's Paterson Building in Manchester

CRUK backs AI-powered, virtual radiotherapy trial projects

Cancer Research UK has provided £5.9 million ($7.7 million) in funding to a project that will explore the use of artificial intelligence in trials of radiotherapy treatments, as well as vir